Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Viewpoint
Nature Reviews Endocrinology 2, 650–651 (1 December 2006) | doi:10.1038/ncpendmet0350
Less is more risky? Growth hormone and insulin-like growth factor 1 levels and cardiovascular risk
&
Abstract
Elevated levels of growth hormone (GH) and insulin-like growth factor 1 (IGF1) in conditions such as acromegaly have been implicated in increased cardiovascular risk. The authors of this Viewpoint argue, however, that hormone deficiency might pose a greater risk than hormone excess, and ask the question—what levels of GH and IGF1 can be considered 'safe'?
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
